Oncology

News

Jazz buys KRAS inhibitors from Redx in $880m deal

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma,

News

GSK backs up its Blenrep rehab bid with survival data

GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it fail

News

Pfizer partners American Cancer Society on health equity

A new $15 million initiative between Pfizer and the American Cancer Society (ACS) aims to tackle one of the most pressing issues in health at the moment – unequal access t

News

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Novartis is continuing a streak of pipeline-building deals with an agreement to buy Germany’s MorphoSys in a transaction that values the cancer-focused biotech at €2.7 billion (around

News

Metagenomi prices IPO and NeOnc joins list of hopefuls

Gene editing start-up Metagenomi and cancer specialist NeOnc Technologies have announced the terms of their initial public offerings, in another sign that investor interes

News

First patient treated with Moderna's PD-1/IDO1 cancer shot

The first patient has been treated in a phase 1/2 clinical trial of an experimental Moderna vaccine designed to generate antibodies against PD-L1 and IDO1 – two targets th

Jazz buys KRAS inhibitors from Redx in $880m deal

GSK backs up its Blenrep rehab bid with survival data

Pfizer partners American Cancer Society on health equity

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Metagenomi prices IPO and NeOnc joins list of hopefuls

First patient treated with Moderna's PD-1/IDO1 cancer shot

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Oncology

Editor's Picks